Reported 3 months ago
Wells Fargo has been sued by four former employees who accuse the bank of mishandling its employee health insurance plan, leading to inflated prescription drug costs. The lawsuit alleges that the bank violated federal law by allowing pharmacy benefit managers to set excessively high prices for medications, including a cancer drug that cost over $69,000, while it was available for as low as $3,750 elsewhere. This proposed class action could affect tens of thousands of Wells Fargo employees and seeks unspecified damages.
Source: YAHOO